PDCD1 and idiopathic pulmonary fibrosis: Following the observation that PD-1 was consistently increased in mediastinal lymph nodes of patients with IPF and tracheobronchial lymph nodes of bleomycin-treated mice compared to control groups, we studied the role of the PD-1 inhibitor, pembrolizumab, in experimental pulmonary fibrosis in mice.